baber/WOPTO huggingface dataset:
Patent AT-E224160-T1 (AT)
Inventor: NELSON THOMAS J
IPC: A47B77/02
Filed: 1999-11-16
Granted: 2002-10-15
Abstract: Disclosed is a modular worktop, and method of assembly, including a surface member, a front edge, and a backsplash, the components preferably being removably attached to each other. Each of the surface member, front edge, and backsplash may be selected from a predetermined group of decorative surfacing options, resulting in a worktop that is aesthetically pleasing to the consumer or person selecting the components. Additionally, each of the components is sized and configured so as to bring assembly and installation within the skill range of the average consumer. Because the front edge is removably attached, the front edge is changeable at the discretion of the consumer, for example, for aesthetic reasons. <IMAGE>
Patent AT-E224312-T1 (AT)
Inventor: PASCOE DAVID MARK
IPC: B60R3/02
Filed: 1999-01-19
Granted: 2002-10-15
Abstract: A power-retractable step assembly for a motor vehicle comprises a substantially sealed housing assembly, a pivoting structure including a step structure, a gear assembly, and a motor assembly. The step structure presents an upper load carrying surface, and the pivoting structure is mounted for pivotal movement about an axis. The gear assembly is disposed in the sealed housing assembly and coupled to the pivoting structure. The motor assembly is drivingly coupled with the gear assembly and is constructed and arranged to pivot the pivoting structure about the axis and thereby drive the pivoting structure between deployed and stored positions. The step structure is moved in an outboard vehicle direction when the pivoting structure is moved from the stored position to the deployed position, and is also moved in a fore-aft vehicle direction when the pivoting structure is moved between the stored and deployed positions. The axis is disposed at an angle such that, as the axis extends upwardly, i) the axis extends in the outboard vehicle direction and ii) the axis extends in a same fore-aft vehicle direction as the fore-aft direction that the step structure moves when the pivoting structure is moved from the stored position to the deployed position.
Patent AT-E248636-T1 (AT)
Inventor: SCHMIDT-TRAUB HENNER
IPC: B01D53/02
Filed: 1999-02-04
Granted: 2003-09-15
Abstract: The present invention relates to a method for recovering and/or removing organic compounds from gas flows, wherein the method comprises the step of:removing the organic compounds from the gas flow using an adsorber anddesorbing the organic compounds using microwaves, characterized in that the adsorber is a finely dispersed mixture of a hydrophilic and a hydrophobic adsorbent.
Patent AT-E241430-T1 (AT)
Inventor: PETERS RALF-PETER
IPC: G01N31/20
Filed: 1999-03-11
Granted: 2003-06-15
Abstract: The comprises at least one sample receiving chamber for a sample liquid, and a distributor channel for sample liquid connected to said at least one sample receiving chamber, with at least one such distributor channel extending from each sample receiving chamber. The sample support further comprises at least one reaction chamber entered by an inflow channel branched off said at least one distributor channel, and a venting opening for each reaction chamber. Each distributor channel and each inflow channel are dimensioned to have the liquid transport through the distributor and inflow channels effected by capillary forces. In each reaction chamber, the entrance region of the inflow channel is provided with a means for generating a capillary force causing the sample liquid to flow from the inflow channel into the reaction chamber.
Patent AT-E217383-T1 (AT)
Inventor: FLORUSS MARKUS
IPC: E06B9/11
Filed: 1999-02-04
Granted: 2002-05-15
Abstract: A roll-up grating has rods (1) laterally guided transversely to the opening and closing direction of displacement of the roll-up grating, and connecting members (3, 16) which interconnect the rods (1) in an articulated manner. The connecting members (3, 16) are made of a single piece and have longitudinal openings for receiving the grating rods (1) with a closed, seamless outer surface. Also disclosed is a process for producing these roll-up gratings.
Patent AT-E222068-T1 (AT)
Inventor: TUMA JAN
IPC: A44B18/00
Filed: 1999-06-01
Granted: 2002-08-15
Abstract: The invention relates to a method for producing a fixing closure element comprising a plurality of interlocking means which are configured with a support (17) as one piece. According to the inventive method, a thermoplastic material is fed to the slit between a pressure tool (3) and a shaping tool (5). A sieve (11) comprising continuous cavities is used as a shaping element on the shaping tool (5). The interlocking means are formed such that the thermoplastic material is at least partially hardened in the cavities of the sieve (11). A shaping tool which comprises a second shaping element (11), said element interacting with the cavities of the sieve, is used on the side of the sieve (13) facing away from the pressure tool (3). The thermoplastic material is shaped using said second shaping element.
Patent AT-E302949-T1 (AT)
Inventor: EYRE DAVID R
IPC: G01N33/53
Filed: 1999-06-17
Granted: 2005-09-15
Abstract: Immunoassays for measuring type II collagen (cartilage) resorption in vivo employ either one or two antibodies. A first antibody binds to EKGPDP (SEQ ID NO:2) but not to EKGPDPLQ (SEQ ID NO:10), where the K symbols refer to lysine or preferably to cross-linking 3-hydroxypyridinium residues. Measurement of analyte binding to the first antibody in serum provides an indication of unmineralized cartilage resorption in vivo. A second antibody binds to EKGPDPLQ (SEQ ID NO:10) but not to EKGPDP (SEQ ID NO:2). Measurement of analyte binding to the second antibody in serum provides an indication of mineralized cartilage resorption in vivo. An indication of total (unmineralized and mineralized) cartilage resorption in vivo is provided by either measurement of analyte binding to the first antibody in urine, or by measurement of the total analyte binding to the first and second antibodies in serum.
Patent AT-E246942-T1 (AT)
Inventor: MORRIS ROBERT E
IPC: A61M1/00
Filed: 1999-06-21
Granted: 2003-08-15
Abstract: A method and apparatus for performing surgery inside the human retina using fluidic internal limiting membrane separation (FILMS) to remove the internal limiting retinal layer from the neural retinal layer at the macula. The method comprises inserting a hollow microcannula between the retinal internal limiting membrane and the neural retinal layer at or near the macula and injecting a sterile fluid, such as sodium hyaluronate, through said microcannula and thereby raising the macular internal limiting membrane retinal layer away from the neural retina such that it can then be removed by conventional means, while simultaneously smoothing the neural retina by localized pressure tamponad. The apparatus comprises a hollow microcannula having a proximal end a distal end and a distal tip. The distal end is shaped to conform tangentially to the surface of the retina. The distal tip is sharply beveled and adapted to discharge a fluid substance and to easily insert under the internal limiting membrane retinal layer and achieve occlusion of the lumen upon minimal insertion, and is sufficiently microscopic as to not substantially injure the neural retina when introduced under the ILM.
Patent AT-E229098-T1 (AT)
Inventor: SCHOENFELDER ECKART
IPC: C23G1/02
Filed: 1999-07-22
Granted: 2002-12-15
Abstract: The inventive aqueous pickling agent on the basis of sulfuric acid or phosphoric acid and hydrogen fluoride for stainless steels, which pickling agent is free of wetting and emulsifying agents, contains (each as 100 wt-% substance) 1.5 to 16 wt-% sulfuric acid or 2.0 to 30 wt-% phosphoric acid as well as 0.5 to 14 wt-% hydrogen fluoride and 0.5 to 15.5 wt-% acid-soluble aromatic nitro compound. An iron(III) compound is not supplied to said pickling agent. Merely in the starting phase, an oxidizing agent can be supplied, which oxidizes iron(II) to form iron(III). As acid-soluble aromatic nitro compound m-nitrobenzene sulfonate and/or 3-nitrophthalate are particularly advantageous. The inventive pickling agent can be used as bath pickle and -when adding 2.5 to 5.5 wt-% magnesium and/or magnesium compound (calculated as Mg)-also as spraying pickle or brush pickle.
Patent AT-E387461-T1 (AT)
Inventor: AHMAD SULTAN
IPC: G01N33/50
Filed: 1999-04-15
Granted: 2008-03-15
Abstract: The present invention is directed to a novel neurotensin-like receptor expressed in the central nervous system of humans. The invention encompasses the receptor protein as well as nucleic acids encoding the protein. In addition, the invention is directed to methods and compositions which utilize the receptor.
Patent AT-E446363-T1 (AT)
Inventor: BENNETT C
IPC: C07H21/04
Filed: 1999-09-23
Granted: 2009-11-15
Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.
Patent AT-E419273-T1 (AT)
Inventor: FISCHER M
IPC: C12N15/09
Filed: 1999-11-11
Granted: 2009-01-15
Abstract: The invention relates to modified and truncated forms of the membrane transport vector penetratin. Such truncated forms include 7-mer peptides that may in themselves include further variation.
Patent AT-E300636-T1 (AT)
Inventor: JONES LISA
IPC: F16C13/00
Filed: 1999-05-21
Granted: 2005-08-15
Abstract: The bone-hard supercalender roll of the present invention comprises: an elongate shaft having a longitudinal axis; a core layer formed of fibrous material circumferentially covering the shaft; means for compressing the core layer along the shaft longitudinal axis; an intermediate layer circumferentially covering the core layer that comprises a first polymeric resin and a heavy textile material; and an outer layer circumferentially covering the intermediate layer that comprises a second polymeric resin and a reinforcing material. In this configuration, the roll can provide the requisite bone-hard surface for calendering applications, but can do so without the surface denting and marring problems associated with filled rolls and the expense of rolls formed of covered metal cores.
Patent DE-04735989-T1 (DE)
Title: Einrichtung, verfahren und programm zur auswahl von voice-daten
Inventor: SATO YASUSHI
IPC: G10L13/08
Filed: 2004-06-03
Abstract: Eine
Stimmdatenauswahlvorrichtung, die Folgendes umfasst:  ein Datenspeicherungsmittel
zum Speichern einer Vielzahl von Stimmdaten, die Stimmwellenformen
ausdrücken;  ein
Suchmittel zum Eingeben von Textinformationen, die einen Text ausdrücken, und
zum Zurückholen
von Stimmdaten, die eine Wellenform einer Stimmeinheit ausdrücken, deren
Lesung der einer Stimmeinheit gemeinsam ist, die den Text aus den
Stimmdaten bildet; und  ein Auswahlmittel zum Auswählen von
jeweils der Stimmdaten, die jeweils der Stimmeinheit entsprechen,
die den Text aus den gesuchten Stimmdaten bildet, so dass ein Wert,
der durch Summieren der Tonhöhenunterschiede
in Grenzbereichen der angrenzenden Stimmeinheiten erhalten wurde,
im ganzen Text minimiert werden kann.
Patent DE-358671-T1 (DE)
IPC: A22C17/00
Filed: 1988-04-25
Abstract: PCT No. PCT/SE88/00207 Sec. 371 Date Oct. 26, 1989 Sec. 102(e) Date Oct. 26, 1989 PCT Filed Apr. 25, 1988 PCT Pub. No. WO88/08250 PCT Pub. Date Nov. 3, 1988.The skeleton bones in a carcass are separated from this in a continuous process course with the aid of supporting manual incisions and a mechanical force applied on the skeleton bones and the carcass, while the carcass is transported along a sliding conveyor hanging in its meat-hook. The speed and the force with which the carcass is transported are guided and controlled independent of each other. The carcass hangs on a meat-hook during the course without attachment so that it can move freely on the hook in all planes, while it is driven forward by means of a pushing arm applied across the carcass. The skeleton part of the carcass which is to be separated is attached by way of a supported meat-hook on the sliding conveyor while the rest of the carcass is driven along the conveyor.
Patent ES-2253136-T1 (ES)
Inventor: DAIFOTIS ANASTASIA G
IPC: A61P3/14
Filed: 1998-07-17
Abstract: Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein. The compounds are bisphosphonates selected from the group consisting of alendronate, cimadronate, clodronate, tiludronate, etridronate, ibandronate, risedronate, piridronate, pamidronate, zolendronate, optionally in combination with a histamine H2 antagonist.
Patent ES-2317819-T1 (ES)
Title: Ensayo de deteccion de alto rendimiento para el canal ionico trpm5.
Inventor: BRYANT ROBERT W
IPC: G01N33/53
Filed: 2006-11-03
Abstract: Un ensayo de detección de alto rendimiento para detectar potenciadores potenciales del canal iónico TRPM5 que comprende: contactar una expresión celular de TRPM5 con una concentración subóptima de un agente que incrementa la concentración intracelular de calcio, en donde la célula ha sido precargada con un colorante fluorescente potencial de membrana; contactar dicha célula con un compuesto potenciador potencial; usar un detector óptico, medir la intensidad fluorescente de dicha célula en la presencia de dicho compuesto potenciador potencial; y comparar la intensidad fluorescente medida con la intensidad fluorescente de una diferente expresión celular de TRPM5 en presencia de una concentración óptima de un agente que aumenta la concentración intracelular de calcio.
Patent ES-2030376-T1 (ES)
IPC: H05H1/46
Filed: 1991-08-29
Abstract: A pair of dissimilarly-sized electrodes (84, 70) are driven by a radiofrequency source to create a plasma. A magnetic field (100) is oriented to be parallel to a surface area on the smaller electrode (84). The field strength increases to either side of that smaller electrode (84). As shown, ions are electrostatically accelerated out of the plasma, but they instead may be accelerated magnetically, electrons may in the alternative be extracted or there may be no accelerating mechanism. <IMAGE>
Patent ES-2041234-T1 (ES)
IPC: G01N33/18
Filed: 1992-08-07
Abstract: The invention relates to the field of pollution detection in an aqueous medium such as for example the detection of pollution of waterways or of waste, and more particularly the field of automatic devices used for this type of detection. According to the invention, an apparatus for automatically detecting pollution in an aqueous medium by testing microorganisms comprises means allowing the freeze-dried colony of the said microorganism to be reconstituted by mixing it in at least one container (14) with a reconstitutional liquid. The automatic apparatus comprises means (15) for turning the container (14) over, which means are capable of allowing the said colony to be mixed with the said reconstitutional liquid without causing even partial destruction of the said colony. <IMAGE>
Patent CY-1112775-T1 (CY)
Inventor: ZEUN SUSAN
IPC: A61P15/18
Filed: 2012-05-18
Abstract: The invention relates to the use of estradiol valerate combined with 17a- cyanomethyl-17-ß-hydroxyestra-4,9-diene-3on (dienogest) for producing a multi-phase combination preparation for the oral therapy of the dysfunctional uterine bleeding in the form of oral contraceptives. Said combination of estradiol valerate with dienogest comprises a first phase consisting of 2 daily dose units of estradiol valerate at 3 mg, a second phase consisting of 2 groups of daily dose units, whereby the first group contains 5 daily dose units of a combination of 2 mg estradiol valerate and 2 mg of dienogest and the second group contains 17 daily dose units consisting of a combination of 2 mg of estradiol valerate and 3 mg dienogest, a third phase consisting of 2 daily dose units having 1 mg estradiol valerate and an additional phase consisting of 2 daily dose units on a pharmaceutically harmless placebo. All of the daily dose units of the multi-phase combination and the pharmaceutically harmless placebo correspond to 28 days. The duration of application comprises at least one menstruation cycle and is dependent on individual wishes of the woman with respect to contraception.
Patent CY-1116889-T1 (CY)
Title: Ροτορας magnus με καλυμμα κυλινδρων οδηγησης
Inventor: ROHDEN ROLF
IPC: B63H9/02
Filed: 2015-11-06
Abstract: Η παρούσα εφεύρεση αναφέρεται σε ένα ρότορα Magnus με έναν διατεταγμένο στην κάτω εξωτερική περιφέρεια του ρότορα Magnus κύλινδρο οδήγησης, ο οποίος πρόσκειται στο ρότορα χωρίς τζόγο, με μία επιφάνεια ανάβασης, η οποία είναι διατεταγμένη κάτω από τον κύλινδρο οδήγησης, και ένα κάλυμμα, το οποίο καλύπτει τον κύλινδρο οδήγησης και την επιφάνεια ανάβασης. Το κάλυμμα σε μία ανοικτή κατάσταση ελευθερώνει τον κύλινδρο οδήγησης και την επιφάνεια ανάβασης έτσι ώστε ένα άτομο να μπορεί να εκτελεί εργασίες στον κύλινδρο πάνω στην επιφάνεια ανάβασης.
Patent CY-1116941-T1 (CY)
Title: Βελτιωση της βιοδιαθεσιμοτητας δραστικων ουσιων με δραστικη ομαδα αμιδινης σε φαρμακα
Inventor: CLEMENT BERND
IPC: A61K31/155
Filed: 2015-11-17
Abstract: Χρήση Ν,Ν'-διυδροξυαμιδίνης (I), Ν,Ν'-διυδροξυαμιδιναιθέρα (II), Ν,Ν'-διυδροξυαμιδινοδιαιθέρα (III), Ν,Ν'-διυδροξυαμιδινεστέρα (IV), Ν,Ν'-διυδροξυαμιδινοδιεστέρα (V), ή 4-υδροξυ-1,2,4-οξαδιαζολίνης (VI) των ανωτέρω τύπων, όπου το R είναι υδρογόνο, αλκυλ- και/ή αρυλ- υπόλοιπο, ως υποκατάστατο δραστικής ομάδας αμιδίνης φαρμάκου για τη βελτίωση της βιοδιαθεσιμότητας του φαρμάκου.
Patent CY-1118228-T1 (CY)
Title: Συνθεσεις φορεα raav που εχουν πρωτεϊνες καψιδιου τροποποιημενης τυροσινης και μεθοδοι για χρηση
Inventor: ZHONG LI
IPC: C12N15/864
Filed: 2016-09-08
Abstract: Αποκαλύπτονται φορείς rAAV τροποποιημένης τυροσίνης, καθώς και μολυσματικά ιοειδή, συνθέσεις και φαρμακευτικά σκευάσματα που τους περιέχουν. Αποκαλύπτονται επίσης μέθοδοι παρασκευής και μέθοδοι για χρήση των αποκαλυπτόμενων μεταλλαγμένων φορέων RAAV πρωτεΐνης καψιδίου φωσφορυλιωμένης τυροσίνης σε μια ποικιλία διαγνωστικών και θεραπευτικών εφαρμογών, συμπεριλαμβανομένων in vivo και ex vivo γονιδιακής θεραπείας, και μεγάλης κλίμακας παραγωγής των φορέων rAAV.
Patent CY-1120068-T1 (CY)
Title: Αντισωματα που συνδεουν και αναστελλουν ενεργοποιητικο υποδοχεα εκφραζομενο επι μυελοειδων κυτταρων-1 (trem-1)
Inventor: STENNICKE VIBEKE WESTPHAL
IPC: C07K16/28
Filed: 2017-10-17
Abstract: Η εφεύρεση αφορά σε αντισώματα που είναι ικανά να συνδέουν ειδικώς TREM-1 και να προλαμβάνουν την ενεργοποίηση TREM-1, μιας πρωτεΐνης που εκφράζεται επί μονοκυττάρων, μακροφάγων και ουδετερόφιλων. Τέτοια αντισώματα βρίσκουν χρησιμότητα στην θεραπεία ατόμων με φλεγμονώδη ασθένεια, όπως ρευματοειδή αρθρίτιδα και φλεγμονώδη νόσο του εντέρου.
Patent CY-1119478-T1 (CY)
Title: Διαγονιδιακα ποντικια με τροποποιημενο ενδογενη γονιδιακο τοπο λαμδα ανοσοσφαιρινης
Inventor: MURPHY ANDREW J
IPC: C12N15/85
Filed: 2017-10-24
Abstract: Παρέχεται ένα διαγονιδιακό ποντίκι που περιλαμβάνει στο γονιδίωμά του έναν ενδογενή γονιδιακό τόπο της λ ελαφριάς αλυσίδας της ανοσοσφαιρίνης που περιλαμβάνει μια διαγραφή του ενδογενούς γονιδιακού συμπλέγματος ποντικιού Vλ1-Jλ3-Cλ3-Jλ1-Cλ1 και μια διαγραφή μιας περιοχής που εκτείνεται από το Vλ2 έως το Jλ2 του ενδογενούς γονιδιακού συμπλέγματος ποντικιού Vλ2-Vλ3-Jλ2-Cλ2-Jλ4-Cλ4. Παρέχονται επίσης κύτταρα και έμβρυα ποντικιού.
Patent CY-1119591-T1 (CY)
Title: Πρωτεϊνες ειδικης συνδεσης και χρησεις αυτων
Inventor: OLD LLOYD J
IPC: G01N33/574
Filed: 2017-10-24
Abstract: Η παρούσα εφεύρεση αφορά σε μέλη ειδικής σύνδεσης, ιδιαιτέρως αντισώματα και θραύσματα αυτών, που συνδέονται προς ενισχυμένο υποδοχέα επιδερμικού αυξητικού παράγοντα (EGFR) και προς τον απο2-7 EGFR ακρωτηριασμό του EGFR. Ιδιαιτέρως, ο επίτοπος που αναγνωρίζεται από μέλη ειδικής σύνδεσης, ιδιαιτέρως αντισώματα και θραύσματα αυτών, ενισχύεται ή εκδηλώνεται κατά την παρεκκλίνουσα του κανονικού μεταμεταφραστική τροποποίηση. Αυτά τα μέλη ειδικής σύνδεσης είναι χρήσιμα στη διάγνωση και θεραπεία καρκίνου. Τα μέλη σύνδεσης της παρούσας εφεύρεσης μπορεί επίσης να χρησιμοποιηθούν στη θεραπεία σε συνδυασμό με χημειοθεραπευτικά ή αντικαρκινικούς παράγοντες ή/και με άλλα αντισώματα ή θραύσματα αυτών.
Patent CY-1124569-T1 (CY)
Title: Φαρμακοτεχνικη μορφη που περιεχει γλυκοπυρρολικο, μεθοδος και συσκευη
Inventor: MANFORD FERGUS
IPC: A61K45/06
Filed: 2020-06-17
Abstract: Γνωστοποιείται μια μέθοδος για την παρασκευή μιας φαρμακευτικής σύνθεσης για πνευμονική χορήγηση η οποία περιέχει ταυτόχρονη άλεση με πεπιεσμένο αέρα γλυκοπυρρολικού και στεατικού μαγνησίου, όπου τα ταυτόχρονα αλεσμένα με πεπιεσμένο αέρα γλυκοπυρρολικό και στεατικό μαγνήσιο υποβάλλονται έπειτα σε ένα στάδιο επεξεργασίας, το οποίο συμπεριλαμβάνει την έκθεση των ταυτόχρονα αλεσμένων με πεπιεσμένο αέρα γλυκοπυρρολικού και στεατικού μαγνησίου σε υγρασία. Γνωστοποιείται επίσης μια σύνθεση που παρασκευάζεται με αυτή τη μέθοδο.
Patent CY-1124093-T1 (CY)
Title: Ανοσογονικες συνθεσεις bordetella bronchiseptica
Inventor: ABDELMAGID OMAR YOUSIF
IPC: A61K39/02
Filed: 2021-05-06
Abstract: Στο παρόν παρέχονται συνθέσεις, συνδυασμοί και μέθοδοι που περιλαμβάνουν Bordetella bronchiseptica και απομονωμένη περτακτίνη, οι οποίες είναι αποτελεσματικές στη θεραπεία ή πρόληψη αναπνευστικών λοιμώξεων, όπως βήχας του κυνοτροφείου, σε ζώα.
Patent GR-880300156-T1 (GR)
Title: Pressurized-air conveyor and metering device
Inventor: LUTTGER HANS
IPC: B65G53/22
Filed: 1989-01-31
Abstract: 1. Method of fluidizing and blowing-in coal dust with compressed air into the conveying and metering line of a cupola furnace, wherein the material to be conveyed is fluidized in the vessel and is blown by means of nozzles out of the fluidized zone intermittently into the conveying and metering line, characterized in that, between the conveying intervals, only pressurized air is blown into the conveying and metering line (016).
Patent GR-930300039-T1 (GR)
Title: Cross-linked, water-absorbent polymer and its use in the production of hygiene items.
Inventor: MERTENS RICHARD
IPC: A61L15/60
Filed: 1993-06-07
Abstract: The invention relates to a cross-linked, water-absorbent polymer obtainable by the polymerisation of a mixture consisting of a) 60 - 99 % wt. unsaturated, polymerisable monomers with acid groups which are neutralised to the extent of at least 30 mol %, b) 0 - 37 % wt. monomers copolymerisable with a), c), 0.1 - 3.0 % wt. of a cross-linking agent and d) 0 - 10 % wt. of a water-soluble polymer, in which polymerisation is brought about with a redox catalyst system containing formamidine sulphinic acid. The polymer is distinguished by a retention of over 28 g 0.9 % aqueous NaCl solution per 1 g of polymer, an absorption of more than 26 g 0.9 % aqueous NaCl solution per 1 g of polymer at a load of 20 g/cm?2 and a residual monomer content of less than 700 ppm and preferably less than 500 ppm. The invention also relates to the use of this polymer in the production of hygiene items.
Patent HR-P20160034-T1 (HR)
Title: Humanized anti-beta7 antagonists and uses thereof
Inventor: DENNIS MARK S
IPC: C07K16/28
Filed: 2016-01-13
Abstract: The invention provides therapeutic anti-beta7 antibodies, compositions comprising, and methods of using these antibodies